Methods, devices and formulations for targeted endobronchial therapy

Patent Citations (62)

Non-Patent Literature (21)

• “Aerosol Therapy in Mechanically Ventilated Patients: Recent Advances and New Techniques” Fink et.al. pp. 183-187.Examiner
• Combes A. et al., “Incidence and outcome of polymicrobial ventilator-associated pneumonia” Chest 121-1618 (2002).Applicant
• Dhand R., et al., “Bronchodilator delivery with metered dose inhalers in mechanically ventilated patients,” Eur Respir J 9:585-595 (1996).Applicant
• Eisenberg, J., et al., “A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Aerosolized tobramycin study group,” Chest 111(4):955-962 (1997).Applicant
• Fink et al., “Optimizing Efficiency of Nebulizers During Mechanical Ventilation: The Effect of Placement and Type in the Ventilator Circuit,” Chest Suppl: 312S, (1999).Applicant
• Fuller, H.D., et al., Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Am. Rev. Respir Dis, 141:440-444 (1989).Applicant
• Hoffken G. and Niederman M.S., “Nosocomial Pneumonia: The Importance of De-escalating Strategy for Antibiotic Treatment of Pneumonia in the ICU” Chest 122:2183 (2002).Applicant
• Levy, J., et al., “Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum,” J Infect Dis 148(6):1069-76 (1983).Applicant
• MacIntyre, N., et al., Aerosol delivery to intubated, mechanically ventilated patients. Crit. Care Med, 13:81-84 (1985).Applicant
• O'Doherty MJ, et al., “Delivery of a nebuilized aerosol to a lung model during mechanical ventilation: effect of ventilator settings and nebulizer type, position, and volume of fill,” Am J Respir Crit Care Med 146:383-388 (????).Applicant
• O'Riordan TG, et al., “Predicting aerosol deposition during neonatal ventilation: feasibilty of beach testing,” Respir Care 39:1162-1168 (1994).Applicant
• O'Riordan et al., “Bench Testing of Nebulizers: A Comparison of Three Methods,” J Aerosol Medicine 12(2):59-66 (1999).Applicant
• O'Riordon TG et al., “Nebulizer function during mechanical ventilation,” Am J Respir Crit Care Med 145:1117-1122 (1992).Applicant
• Palmer LB, et al., “Aerosolized antibiotics in mechanically ventilated patients: delivery anf response,” Crit Care Med 26:31-39 (1998).Applicant
• Pennington, J.E., “Penetration of antibiotics into respiratory secretions,” Rev Infect Dis 3(1):67-73 (1981).Applicant
• Ramsey, B.W., et al., “Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic fibrosis inhaled tobramycin study group,” N Engl J Med 340(1):23-30 (1999).Applicant
• Rello J. et al., “Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database” Chest 122:2115 (2002).Applicant
• Thomas SH et al., “Delivery of Ultrasonic Nebulized Aerosols to a Lung Model during Mechanical Ventilation,” Am. Rev. Respir. Dis. 148:872 (1993).Applicant
• Wood et al., “Aerosolized Antimicrobial Therapy in Acutely Ill Patients,” Pharmacotherapy 20(2):166-181 (2000).Applicant
• Wood et al., “Aerosolized Ceftazidime for Prevention of Ventilator-associated Pnemonia and Drug Effects on the Proinflammatory Response in Critically Ill Trauma Patients” Pharmacotherapy 22(8):972-982 (2002).Applicant
• Fink et al., “Aerosol therapy in mechanically ventilated patients: recent advances and new techniques,” Sem. Resp. Crit. Care Med. 21(3):183-201 (2000).Applicant